Completed NA INTERVENTIONAL 2-arm NCT03250286

Role of EUS in High Risk of Choledocholithiasis

Sponsor: Woo Hyun Paik

Interventions ERCP EUS

Updated 10 times since 2017 Last updated: Mar 15, 2021 Started: Jul 25, 2017 Primary completion: Jun 5, 2020 Completion: Jun 5, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03250286, this NA trial focuses on Choledocholithiasis and remains completed. Sponsored by Woo Hyun Paik, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Apr 2021 [monthly]

Completed NA

▶ Show 5 earlier versions

Oct 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2019 — Oct 2020 [monthly]

Recruiting NA
Apr 2019 — Jun 2019 [monthly]

Recruiting NA
Jun 2018 — Apr 2019 [monthly]

Recruiting NA
Sep 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Woo Hyun Paik

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea